Energy tends to respond first, mood and focus follow within a week or so, and the longer-term, structural benefits build quietly over months
Clinical data shows injectable formulations reach therapeutic levels faster and maintain steadier plasma concentrations, which translates to more consistent week-to-week hunger reduction and weight loss trajectory
The frequency of gastrointestinal adverse effects decreases over time after the initial 8 weeks treatment period [44,49-51]
doi:10.1093/humupd/dmx032 Miyashita-Ishiwata M, Sabeh E, Reschke M, et al
In fact, some studies have shown microglial and astrocytic activation in the CNS of COVID-19 patients who had more severe conditions and encephalopathies (Pilotto and Padovani 2020
Targeting metabolism to improve the tumor microenvironment for cancer immunotherapy